GS have a broker note out today with a BUY rating & price target of $5.90. I can see this rising after the results briefing.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025